EIDP, Inc. 2023 Form 10-K Summary
Business context and reporting period
EIDP, Inc. filed a combined Form 10-K with Corteva, Inc. for the fiscal year ended December 31, 2023. Corteva owns all 200 issued EIDP common shares; EIDP has reduced disclosure requirements and remains a separate reporting company. EIDP’s preferred stock remains outstanding to third parties.
The business operates through Corteva’s two reportable segments: Seed and Crop Protection. The filing presents annual results; a separate fourth-quarter financial statement summary is not provided.
Key financial metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net sales | $17,226 million | $17,455 million | Down 1% |
| Income from continuing operations | $926 million | $1,182 million | Down 22% |
| Net income attributable to EIDP | $730 million | $1,123 million | Down 35% |
| Income from discontinued operations | $(194) million | $(58) million | Higher loss |
| Interest expense | $253 million | $124 million | Up $129 million |
| Effective tax rate | 13.7% | 14.4% | Improved |
| Cash flow from continuing operations | $1,408 million | $879 million | Up $529 million |
| Capital expenditures | $595 million | $605 million | Down $10 million |
Reported EIDP net sales were essentially unchanged from Corteva’s consolidated sales. Based on reported figures, continuing-operations net margin was approximately 5.4% and EIDP’s segment operating EBITDA was $3,491 million, or approximately 20.3% of sales. These margin calculations are derived from filing data and are not GAAP measures.
- Seed sales increased 5% to $9,472 million; segment operating EBITDA increased 28% to $2,117 million.
- Crop Protection sales declined 9% to $7,754 million; segment operating EBITDA declined 18% to $1,374 million.
- Cost of goods sold declined to $9,920 million, or 58% of sales, from 60% in 2022.
- Research and development expense increased 10% to $1,337 million, or 8% of sales.
- Restructuring and asset-related charges were $336 million, including $217 million associated with the Crop Protection Operations Strategy Restructuring Program and $72 million of accelerated prepaid royalty amortization.
- Cash, cash equivalents and marketable securities totaled $2,742 million at year-end, compared with $3,315 million in 2022.
- EIDP reported $198 million of short-term borrowings and $2,291 million of long-term debt. The $789 million related-party loan outstanding at December 31, 2022 was repaid during 2023.
- The company had $5.5 billion of committed revolving credit capacity available at year-end and approximately $6.0 billion of committed and uncommitted unused credit lines. Debt covenants were satisfied.
Material changes versus the prior comparable period
- Sales declined modestly because a 10% volume decrease and 1% unfavorable currency impact outweighed a 7% price increase and 3% favorable portfolio and other effects.
- Crop Protection was pressured by channel inventory destocking, strategic product exits and delayed farmer purchases, particularly in Latin America and North America.
- Seed performance improved through pricing, technology adoption, lower net royalty expense and productivity actions, despite lower volumes and unfavorable currency.
- Interest expense increased materially because of higher interest rates, new debt issued in May 2023 and increased short-term borrowing.
- Other expense increased to $448 million from $60 million, primarily reflecting higher foreign-exchange losses, estimated settlement reserves and non-operating pension and other post-employment costs.
- Stoller and Symborg were acquired on March 1, 2023 for $1.220 billion and $370 million, respectively. The acquisitions added approximately $512 million of goodwill and $945 million of other intangible assets; their 2023 operating impact was not material to the consolidated financial statements.
- Investing cash outflows increased to $1.987 billion, primarily because of the acquisitions.
- EIDP’s cash flow from continuing operations increased to $1.408 billion, helped by lower receivables and inventories. Cash flow remains seasonal because agricultural sales and customer collections are concentrated around planting and harvest cycles.
Guidance, outlook, commentary and unusual items
Management described the 2024 agricultural outlook as constructive, with expected continued demand for grain, oilseeds and biofuels and modest Crop Protection industry improvement as channel inventories normalize. The combined filing provides 2024 guidance for Corteva’s business, but does not provide separate EIDP-only guidance:
| 2024 measure | Guidance |
|---|---|
| Net sales | $17.4 billion–$17.7 billion |
| Operating EBITDA | $3.5 billion–$3.7 billion |
| Operating EPS | $2.70–$2.90 |
| Cash flow from continuing operations | $2.1 billion–$2.6 billion |
| Free cash flow | $1.5 billion–$2.0 billion |
- The Crop Protection restructuring program is expected to generate approximately $100 million of run-rate savings by 2025. Additional 2024 restructuring charges are expected to be approximately $180 million–$230 million, with total program charges estimated at $410 million–$460 million and future cash payments of $90 million–$120 million.
- Management expects approximately $630 million of 2024 capital expenditures and approximately $1.0 billion of 2024 share repurchases under Corteva’s buyback plan.
- Discontinued-operations losses of $194 million in 2023 primarily reflected PFAS-related settlements and remediation activities, including approximately $175 million of after-tax charges.
- The Nationwide Water District PFAS settlement involved a $1.185 billion settlement fund funded by Chemours, DuPont and Corteva. Final court approval was expected in the first quarter of 2024; the filing states that an accrual had been established at December 31, 2023.
- Environmental remediation accruals were $501 million, with reasonably possible exposure of approximately $655 million above accrued amounts under adverse changes in circumstances.
- Other material contingencies include FTC and private antitrust litigation, Lorsban-related personal injury and remediation claims, Bayer licensing and patent disputes, legacy PFAS litigation, and indemnification obligations arising from the Corteva separation.
- Management reported no known cybersecurity incident that had materially affected operations or financial condition, but identified cybersecurity, intellectual property theft and supply-chain disruption as continuing risks.
Most important facts for an investor to verify
- Confirm the distinction between EIDP standalone results and Corteva consolidated results, particularly EIDP’s higher interest expense and related-party transactions.
- Review the sustainability of the 2023 Seed margin improvement and whether Crop Protection volumes and channel inventories recover as expected.
- Reconcile 2024 guidance to GAAP measures and assess the effect of restructuring charges, interest expense, taxes and seasonal working capital.
- Evaluate PFAS, environmental, antitrust, product liability and patent contingencies, including potential exposure above recorded accruals and reliance on indemnification from Chemours, DuPont and Dow.
- Assess leverage, debt maturities, variable-rate borrowing exposure and the availability of committed credit facilities.
- Review goodwill of $10.6 billion and other intangible assets of $9.6 billion, with particular attention to the assumptions supporting the seed reporting unit impairment analysis.
- Consider the effect of foreign exchange, particularly the Argentine peso, Brazilian real, euro, Canadian dollar and Chinese renminbi, on earnings and cash flow.
- Verify that the Stoller and Symborg acquisitions, restructuring actions and related internal-control exclusions are appropriately reflected in future results.